Rescoring of Patients with Gestational Trophoblastic Neoplasia Using Modified Scoring System By Figo

Authors

  • Taner Turan Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Serap Bozok Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Nurettin Boran Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Nejat Özgül Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Sevgi Koç Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Gökhan Tulunay Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Özlem Kerimoğlu Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara
  • Faruk Köse Ankara Etlik Maternity and Women’s Health Teaching Hospital, Gynecologic Oncology Division, Ankara

Keywords:

Gestational Trophoblastic Neoplasia, Scoring system

Abstract

OBJECTIVE: The scoring system of GTN determines the treatment modalities. Scoring system was first improved by Bagshawe et al. in 1976. World Health Organisation (WHO) had modified this scoring system in 1983. FIGO reviewed and rev ised the WHO scoring system in 2000. In this study, the change in scores and risk groups of patients scored according to WHO, were analy zed when the
patients were re-evaluated according to FIGO
STUDY DESIGN: The records of 71 patients with GTN were reviewed between 1994 and 2002. The f irst scoring system that determines the treatment modality was WHO scoring system in all patients. All patients were rescored by the FIGO’s modif ied scoring system retrospectively.
RESULTS: In this study, 35.2% of 71 patients’ score wasn’t changed, while increased in 14.1% and decreased in 50.7%. In high-risk group (n=29) by the WHO scoring system the risk score was same in 31% of patients, increased in 27.6% and decreased in 41.4%. In the intermediate-risk group (n=15) risk score was same in 33.3% and decreased in 66.7%. In the low-risk group (n=27) the risk score was
same in 40.7%, increased in 7.4% and decreased in 51.9% of patients.
CONCLUSION: Today the uncertainty of the scoring systems still remains. The univariant and the multivariant analyses of the studies about the effect of prognostic factors that are used in scoring systems on the treatment success declare different results. The new studies will show the validity of the last scoring system.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2006-12-20

How to Cite

1.
Turan T, Bozok S, Boran N, Özgül N, Koç S, Tulunay G, Kerimoğlu Özlem, Köse F. Rescoring of Patients with Gestational Trophoblastic Neoplasia Using Modified Scoring System By Figo. Gynecol Obstet Reprod Med [Internet]. 2006Dec.20 [cited 2022Aug.17];12(3):192-6. Available from: https://www.gorm.com.tr/index.php/GORM/article/view/602

Issue

Section

Gynecology and Gynecological Oncology

Most read articles by the same author(s)

1 2 3 > >>